|
Volumn 91, Issue 4, 2004, Pages
|
The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AIEOP ACUTE LYMPHOBLASTIC LEUKEMIA PROTOCOL;
ANTINEOPLASTIC AGENT;
ASPARAGINASE;
COLORING AGENT;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DIAGNOSTIC AGENT;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISONE;
TETRAZOLIUM;
THIAZOLE DERIVATIVE;
THIAZOLYL BLUE;
VINCRISTINE;
ACUTE LYMPHOCYTIC LEUKEMIA;
ADOLESCENT;
AGE;
ARTICLE;
CHILD;
DRUG RESISTANCE;
FEMALE;
HUMAN;
IN VITRO STUDY;
MALE;
MULTIVARIATE ANALYSIS;
PREDICTION AND FORECASTING;
PRESCHOOL CHILD;
REMISSION;
SEX DIFFERENCE;
6-MERCAPTOPURINE;
ADOLESCENT;
AGE FACTORS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
CHILD;
CHILD, PRESCHOOL;
COLORING AGENTS;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE;
MALE;
METHOTREXATE;
MULTIVARIATE ANALYSIS;
PREDICTIVE VALUE OF TESTS;
PREDNISONE;
REMISSION INDUCTION;
SEX FACTORS;
TETRAZOLIUM SALTS;
THIAZOLES;
VINCRISTINE;
|
EID: 16544364228
PISSN: 00074551
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|